PursueCare Unveils Next-Gen Digital Therapeutics at Denver Addiction Conference
Denver, Tuesday, 22 April 2025.
PursueCare showcased innovative virtual addiction treatments focusing on digital therapeutics at the ASAM Conference in Denver, highlighting advancements in patient care technologies and policy impact.
Distinguished Leadership Recognition
PursueCare’s Medical Director, Dr. Jason Kirby, has been awarded the prestigious 2025 Distinguished Fellow recognition by ASAM, marking a significant milestone in the company’s leadership in addiction medicine [1]. Dr. Kirby’s recognition comes as PursueCare prepares to showcase its innovative treatment platform at the conference scheduled for April 24-27, 2025, in Denver [1].
Breakthrough Digital Therapeutic Solutions
The company is set to demonstrate its FDA-authorized digital therapeutics, including RESET® and RESET-O®, which represent significant advances in virtual addiction treatment [1]. These tools provide comprehensive 24/7 recovery support, integrating cognitive behavioral therapy with contingency management and real-time progress tracking through secure smartphone applications [1]. Currently, PursueCare’s services extend across seven U.S. states, including Connecticut, Kentucky, Massachusetts, Maine, New Hampshire, Ohio, and West Virginia [1].
Conference Agenda and Impact
The ASAM Conference’s comprehensive schedule includes crucial networking opportunities and educational sessions [6]. Beginning Sunday, April 27, 2025, the conference will feature scholarship networking breakfast meetings and multiple concurrent sessions focusing on addiction medicine advancement [6]. This platform provides PursueCare with a significant opportunity to demonstrate how digital therapeutics can enhance traditional treatment approaches [1].
Future Implications for Addiction Treatment
PursueCare’s presentation at ASAM represents a broader shift toward technology-integrated healthcare solutions [1]. The company’s multi-disciplinary approach, combining medical care, counseling, psychiatry, and pharmacy services, demonstrates the evolving landscape of addiction treatment [1]. This comprehensive care model, supported by digital therapeutics, positions PursueCare at the forefront of modern addiction medicine [alert! ‘specific outcome metrics not yet available as conference is upcoming’].